Nuvation Bio (NUVB)
US Market

Nuvation Bio (NUVB) Financial Statements


Nuvation Bio Financial Overview

Nuvation Bio's market cap is currently ―. The company's EPS TTM is $-0.314; its P/E ratio is -9.22; Nuvation Bio is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.83M$ -19.65M$ -20.64M$ -26.70M$ -21.78M
EBITDA$ -20.78M$ -23.02M$ -23.80M$ -28.80M$ -21.98M
Net Income Common Stockholders$ -13.79M$ -18.55M$ -20.64M$ -19.14M$ -18.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 611.21M$ 619.34M$ 630.90M$ 646.61M$ 661.01M
Total Assets$ 621.48M$ 630.87M$ 641.41M$ 657.06M$ 672.14M
Total Debt$ 4.01M$ 4.46M$ 3.68M$ 3.97M$ 4.26M
Net Debt$ -607.21M$ -614.88M$ -627.22M$ -642.64M$ -656.75M
Total Liabilities$ 16.36M$ 19.28M$ 16.78M$ 15.99M$ 672.14M
Stockholders Equity$ 605.12M$ 611.59M$ 624.60M$ 641.07M$ 655.08M
Cash Flow-
Free Cash Flow$ -15.04M$ -16.21M$ -17.54M$ -19.31M$ -16.23M
Operating Cash Flow$ -15.03M$ -16.18M$ -17.52M$ -19.30M$ -16.17M
Investing Cash Flow$ 33.16M$ -9.59M$ 37.35M$ -52.00M$ -21.83M
Financing Cash Flow$ 120.00K$ 77.00K$ 133.00K$ 298.00K$ 407.00K
Currency in USD

Nuvation Bio Earnings and Revenue History

Nuvation Bio Debt to Assets

Nuvation Bio Cash Flow

Nuvation Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis